Category: Accuray Inc.Syndicate content

Medtronic: Defibrillator market is stabilizing | Wall Street Beat

September 6, 2012 by MassDevice staff

The prolonged slump in the U.S. defibrillator market appears to have stabilized, according to medical device company Medtronic.

MassDevice.com Wall Street Beat

Medtronic (NYSE:MDT) said the slump that's hit its bread-and-butter cardiac rhythm management division where it hurts appears to have stabilized, despite the 5% sales slide during its fiscal 1st quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Battle in Silicon Valley: Device makers trade barbs in the fight to gain share in robot assisted procedures

August 16, 2012 by Arezu Sarvestani

The best way to beat Intuitive Surgical out of the corner it has on the prostate cancer treatment market is by amping up the aggression, radiosurgery veteran and Varian chief medical officer John Adler tells MassDevice.com.

boxing gloves

Radiosurgery innovator and medtech veteran John Adler is ready for a fight.

The outspoken inventor of Accuray's (NSDQ:ARAY) CyberKnife system, as well as the company's founder and former CEO, Adler is an evangelist for radiosurgery and its potential in a variety of applications.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Study: Robot assisted prostate surgery may lower rates of incontinence, impotence

August 9, 2012 by MassDevice staff

Prostate surgery with robotic assistance may cause less impotence and incontinence than laparoscopic surgery, according to a small Italian study.

da Vinci robot assisted surgery

Robot assisted prostate surgery may lower rates of urinary incontinence and post-surgery impotence when compared with minimally invasive laparoscopy, according to a small Italian study.

The study only comprised 120 patients who were randomized to receive a prostatectomy with either an unnamed robot assistant or with tiny tools manipulated by hand. All surgeries were performed by a single surgeon.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Cyberknife: Man, that robot sure can dance

July 23, 2012 by MassDevice

See video

In this 2009 video from the American Society of Radiation Oncology annual meeting, employees from Sunnyvale, Calif.-based Accuray (NSDQ:ARAY) show off their dance moves.

Accuray nabs imaging systems maker Morphormics for $5.7M

July 16, 2012 by MassDevice staff

Radiosurgery devices company Accuray acquires medical imaging software systems maker Morphormics in a deal worth about $5.7 million.

Accuray logo

Accuray (NSDQ:ARAY) signed a definitive agreement to acquire medical imaging software systems maker Morphormics for $5.7 million, the company announced today.

Privately held Morphormics, founded by faculty of the University of North Carolina at Chapel Hill, develops software that recognizes and extracts anatomical structures from medical images.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

U.S. orthopedics on the upswing, analysts say | Wall Street Beat

June 27, 2012 by MassDevice staff

A new survey of U.S. hip and knee surgeons adds to Wall Street analysts' confidence that the orthopedics market is looking up.

MassDevice.com Wall Street Beat

Wall Street analysts are predicting with increasing confidence that the U.S. orthopedics market is on the upswing following an industry survey suggesting a coming increase in procedure volumes.

A MEDACorp orthopedics survey of 65 U.S. hip and knee surgeons found improvements in 12-month procedure volume expectations and increased patient willingness for surgery, according to an investment note from Leerink Swann analyst Richard Newitter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abiomed slides on reimbursement risk rumors | Wall Street Beat

May 22, 2012 by MassDevice staff

Abiomed says it hasn't heard of any Medicare reimbursement concerns, but a note from a Wall Street analyst sends shares down 6%.; also, Accuray teams up with the German Cancer Research Center; AngioDynamics closes the $335M Navilyst merger; athenahealth may be eyeing Epocrates; Covidien launches offering to pay off senior notes; plus, a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

Abiomed (NSDQ:ABMD) slid 6% in late afternoon trading following a note from a Wall Street analyst warning about Medicare reimbursement concerns for the company's star Impella heart pumps.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp